Organovo Holdings Stock Analysis

ONVO Stock  USD 1.00  0.03  2.91%   
Organovo Holdings is overvalued with Real Value of 0.89 and Hype Value of 1.0. The main objective of Organovo Holdings stock analysis is to determine its intrinsic value, which is an estimate of what Organovo Holdings is worth, separate from its market price. There are two main types of Organovo Holdings' stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect Organovo Holdings' performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of Organovo Holdings' stock to identify patterns and trends that may indicate its future price movements.
The Organovo Holdings stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Organovo Holdings is usually not traded on Thanksgiving Day, Christmas Day, New Year 's Day, Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday, Memorial Day, Juneteenth Holiday, Independence Day, Labour Day. Organovo Stock trading window is adjusted to America/New York timezone. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Organovo Holdings' ongoing operational relationships across important fundamental and technical indicators.
  
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Organovo Holdings. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in real.
To learn how to invest in Organovo Stock, please use our How to Invest in Organovo Holdings guide.

Organovo Stock Analysis Notes

The company has price-to-book ratio of 1.64. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Organovo Holdings recorded a loss per share of 2.16. The entity last dividend was issued on the 19th of August 2020. The firm had 1:20 split on the 19th of August 2020. Organovo Holdings, Inc., a biotechnology company, focuses on developing 3D tissues that recapitulate key aspects of human disease. The company was incorporated in 2007 and is headquartered in Solana Beach, California. Organovo Holdings operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 9 people. To find out more about Organovo Holdings contact Keith Murphy at (858) 224-1000 or learn more at https://www.organovo.com.

Organovo Holdings Investment Alerts

Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Organovo Holdings' investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Organovo Holdings or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
Organovo Holdings had very high historical volatility over the last 90 days
Organovo Holdings has some characteristics of a very speculative penny stock
Organovo Holdings has a very high chance of going through financial distress in the upcoming years
The company reported the previous year's revenue of 370 K. Net Loss for the year was (17.26 M) with loss before overhead, payroll, taxes, and interest of (8.52 M).
Organovo Holdings currently holds about 26.19 M in cash with (12.41 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.01, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Organovo Holdings has a frail financial position based on the latest SEC disclosures
Latest headline from benzinga.com: Why Organovo Stock Is Up Today

Organovo Holdings Upcoming and Recent Events

Earnings reports are used by Organovo Holdings to provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Organovo Holdings previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
8th of February 2024
Upcoming Quarterly Report
View
11th of July 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
11th of July 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of March 2023
Last Financial Announcement
View

Organovo Largest EPS Surprises

Earnings surprises can significantly impact Organovo Holdings' stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2019-11-07
2019-09-30-1.2-1.00.216 
2019-08-08
2019-06-30-1.2-1.00.216 
2017-11-09
2017-09-30-2-1.80.210 
View All Earnings Estimates

Organovo Stock Institutional Investors

Have you ever been surprised when a price of an equity instrument such as Organovo Holdings is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Organovo Holdings backward and forwards among themselves. Organovo Holdings' institutional investor refers to the entity that pools money to purchase Organovo Holdings' securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Shares
Ubs Group Ag2023-12-31
2.6 K
Advisor Group Holdings, Inc.2023-12-31
2.1 K
Albion Financial Group (utah)2023-12-31
1.9 K
Huntington National Bank2023-12-31
750
Wells Fargo & Co2023-12-31
410
Bank Of America Corp2023-12-31
399
Mcglone Suttner Wealth Management Inc2023-12-31
325
Steward Partners Investment Advisory, Llc2023-12-31
230
Coppell Advisory Solutions Llc2023-12-31
125
Vanguard Group Inc2023-12-31
353.6 K
Blackrock Inc2023-12-31
147.5 K
Note, although Organovo Holdings' institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Organovo Market Capitalization

The company currently falls under 'Micro-Cap' category with a current market capitalization of 10.08 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Organovo Holdings's market, we take the total number of its shares issued and multiply it by Organovo Holdings's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

Organovo Profitablity

Organovo Holdings' profitability indicators refer to fundamental financial ratios that showcase Organovo Holdings' ability to generate income relative to its revenue or operating costs. If, let's say, Organovo Holdings is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Organovo Holdings' executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Organovo Holdings' profitability requires more research than a typical breakdown of Organovo Holdings' financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
Last ReportedProjected for Next Year
Return On Tangible Assets(2.60)(2.73)
Return On Capital Employed 1.76  1.68 
Return On Assets(2.60)(2.73)
Return On Equity 8.21  8.62 

Management Efficiency

Organovo Holdings has return on total asset (ROA) of (0.7277) % which means that it has lost $0.7277 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (1.3407) %, meaning that it created substantial loss on money invested by shareholders. Organovo Holdings' management efficiency ratios could be used to measure how well Organovo Holdings manages its routine affairs as well as how well it operates its assets and liabilities. As of the 25th of April 2024, Return On Equity is likely to grow to 8.62, while Return On Tangible Assets are likely to drop (2.73). At this time, Organovo Holdings' Total Assets are very stable compared to the past year. As of the 25th of April 2024, Total Current Assets is likely to grow to about 37.5 M, while Other Current Assets are likely to drop about 882.9 K.
Last ReportedProjected for Next Year
Book Value Per Share(2.46)(2.34)
Net Current Asset Value 0.00  0.00 
Tangible Asset Value 0.00  0.00 
Tangible Book Value Per Share(2.46)(2.34)
Enterprise Value Over EBITDA(8.65)(9.08)
Price Book Value Ratio(21.16)(22.21)
Enterprise Value Multiple(8.65)(9.08)
Price Fair Value(21.16)(22.21)
Enterprise Value6.4 M6.1 M
The analysis of Organovo Holdings' management efficiency is an essential part of evaluating and assessing the financial and operational performance of the entity. It is also vital to analyze Organovo Holdings' future growth prospects and the overall market conditions to determine the value and potential of its stock. The analysis involves studying a range of financial metrics such as revenue, earnings, profit margins, cash flow, debt, market share, and external factors such as economic trends, industry outlook, competition, and government regulations. The goal of Organovo Stock analysis is to determine whether it is undervalued, fairly valued, or overvalued and to make informed investment decisions.
Beta
0.904

Technical Drivers

As of the 25th of April, Organovo Holdings holds the Semi Deviation of 3.98, risk adjusted performance of 0.0264, and Coefficient Of Variation of 3587.41. Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of Organovo Holdings, as well as the relationship between them. Put it differently, you can use this information to find out if the company will indeed mirror its model of past market data, or the prices will eventually revert. We were able to interpolate and analyze data for nineteen technical drivers for Organovo Holdings, which can be compared to its competitors. Please check Organovo Holdings downside deviation, treynor ratio, as well as the relationship between the Treynor Ratio and expected short fall to decide if Organovo Holdings is priced some-what accurately, providing market reflects its current price of 1.0 per share. Given that Organovo Holdings is a hitting penny stock territory we advise to closely look at its total risk alpha.

Organovo Holdings Price Movement Analysis

Execute Study
The output start index for this execution was nine with a total number of output elements of fifty-two. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Organovo Holdings middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Organovo Holdings. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.

Organovo Holdings Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Organovo Holdings insiders, such as employees or executives, is commonly permitted as long as it does not rely on Organovo Holdings' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Organovo Holdings insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

Organovo Holdings Predictive Daily Indicators

Organovo Holdings intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Organovo Holdings stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

Organovo Holdings Forecast Models

Organovo Holdings' time-series forecasting models are one of many Organovo Holdings' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Organovo Holdings' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

About Organovo Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how Organovo Holdings prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Organovo shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Organovo Holdings. By using and applying Organovo Stock analysis, traders can create a robust methodology for identifying Organovo entry and exit points for their positions.
Last ReportedProjected for Next Year
Pretax Profit Margin(36.39)(38.20)
Operating Profit Margin(7.79)(8.17)
Net Loss(36.39)(38.20)
Gross Profit Margin 0.24  0.23 

Be your own money manager

As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Organovo Holdings to your portfolios without increasing risk or reducing expected return.

Did you try this?

Run Bond Analysis Now

   

Bond Analysis

Evaluate and analyze corporate bonds as a potential investment for your portfolios.
All  Next Launch Module
When determining whether Organovo Holdings offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Organovo Holdings' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Organovo Holdings Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Organovo Holdings Stock:
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Organovo Holdings. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in real.
To learn how to invest in Organovo Stock, please use our How to Invest in Organovo Holdings guide.
You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.

Complementary Tools for Organovo Stock analysis

When running Organovo Holdings' price analysis, check to measure Organovo Holdings' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Organovo Holdings is operating at the current time. Most of Organovo Holdings' value examination focuses on studying past and present price action to predict the probability of Organovo Holdings' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Organovo Holdings' price. Additionally, you may evaluate how the addition of Organovo Holdings to your portfolios can decrease your overall portfolio volatility.
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
CEOs Directory
Screen CEOs from public companies around the world
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Equity Valuation
Check real value of public entities based on technical and fundamental data
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Is Organovo Holdings' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Organovo Holdings. If investors know Organovo will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Organovo Holdings listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(2.16)
Revenue Per Share
0.027
Quarterly Revenue Growth
(0.96)
Return On Assets
(0.73)
Return On Equity
(1.34)
The market value of Organovo Holdings is measured differently than its book value, which is the value of Organovo that is recorded on the company's balance sheet. Investors also form their own opinion of Organovo Holdings' value that differs from its market value or its book value, called intrinsic value, which is Organovo Holdings' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Organovo Holdings' market value can be influenced by many factors that don't directly affect Organovo Holdings' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Organovo Holdings' value and its price as these two are different measures arrived at by different means. Investors typically determine if Organovo Holdings is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Organovo Holdings' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.